Chapter 7. Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors
- Peter J. Quesenberry3,
- Gary S. Stein3,
- Bernard G. Forget4,
- Sherman M. Weissman4
Published Online: 13 MAY 2002
DOI: 10.1002/0471223956.ch7
Copyright © 1998 by Wiley-Liss, Inc.
Book Title

Stem Cell Biology and Gene Therapy
Additional Information
How to Cite
Huard, J., Goins, W. F., Akkaraju, G. R., Krisky, D., Oligino, T., Marconi, P., Day, C. S. and Glorioso, J. C. (2002) Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors, in Stem Cell Biology and Gene Therapy (eds P. J. Quesenberry, G. S. Stein, B. G. Forget and S. M. Weissman), John Wiley & Sons, Inc., New York, USA. doi: 10.1002/0471223956.ch7
Editor Information
- 3
University of Massachusetts, Worcester, Massachusetts
- 4
Yale University School of Medicine, New Haven, Connecticut
Publication History
- Published Online: 13 MAY 2002
- Published Print: 27 AUG 1998
ISBN Information
Print ISBN: 9780471146568
Online ISBN: 9780471223955
- Summary
- Chapter
Keywords:
- cell therapy;
- gene therapy;
- HSV-1;
- gene delivery;
- muscle;
- HSV-1 vector;
- impediments;
- spinal cord neurons;
- intramuscular inoculation
Summary
The recovery of injured muscle depends on several factors, such as muscle regeneration, revascularization, and reinnervation. Recovery can be improved with gene therapy procedures that deliver substances that promote the recovery of the injured muscle and may also prevent complications associated with muscle healing and contractures. Two different approaches have been employed to deliver genes to muscle: cell therapy based on myoblast transplantation (MT) and gene therapy (GT) using viral and nonviral vectors. These approaches are discussed in this chapter.
